Company profile
Pangea Bio
Novel Therapies for Central Nervous System Disorders
- Industry
- Biotechnology Research
- Employees
- 26
- Headquarters
- London
- Founded
- 2021
- Office locations
- 1
Pangea Bio company summary
Pangea Bio is a company in the Biotechnology Research industry, headquartered in London, founded in 2021. On LinkedIn the company has around 26 employees.
What technology does Pangea Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Pangea Bio
Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.
Where is Pangea Bio located?
Pangea Bio lists 1 location.
Compare companies similar to Pangea Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Pangea Bio pangeabio.com | Biotechnology Research | 26 | 2021 | London |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Pangea Bio
What does Pangea Bio do?
Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.
How many employees does Pangea Bio have?
Pangea Bio has around 26 employees on LinkedIn.
Where is Pangea Bio headquartered?
Pangea Bio is headquartered in London.
When was Pangea Bio founded?
Pangea Bio was founded in 2021.
Build a lead list from companies like Pangea Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.